Caixin
财新亚洲愿景论坛2025-嘉宾 财新亚洲愿景论坛2025-嘉宾
财新亚洲愿景论坛2024-嘉宾 财新亚洲愿景论坛2024-嘉宾
胡舒立
Derek Yuan Derek Yuan
China General Manager, Candid Therapeutics Candid Therapeutics中国区总经理
Derek Yuan is currently China General Manager of Candid Therapeutics, a company focused on developing T-cell engagers for the treatment of autoimmune disorders. Previously, he founded Prescient Advisory, an advisory company focused on China-US life sciences transactions, and also served as Executive Director of Corporate Development at Zai Lab from 2018-2022. Derek also has experience in healthcare fund management at QUAD Investment Management and started his career at UBS in pharmaceuticals equity research. Derek Yuan 现任 Candid Therapeutics 中国区总经理，该公司专注于开发用于治疗自身免疫性疾病的T细胞衔接器（T-cell engagers）。

在此之前，他创立了 Prescient Advisory，一家专注于中美生命科学跨境交易的咨询公司，并于 2018 至 2022 年期间担任再鼎医药（Zai Lab）企业发展部执行董事，负责公司战略合作与投融资事务。

Derek 此前还在 QUAD Investment Management 从事医疗健康领域基金管理，并在职业生涯早期任职于瑞银集团，从事制药行业股票研究工作。